Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
First American
FAF
$7.51B
| $1.02M | ﹤0.01% |
19,959
+594
| +3% | +$30.8K |
|
2652
Silgan Holdings
SLGN
$4.46B
| $1.01M | ﹤0.01% |
27,615
-9,055
| -25% | -$332K |
|
|
NLSN
2653
CALL
DELISTED
Nielsen Holdings plc
NLSN
| $1.01M | ﹤0.01% |
71,600
| – | – |
|
2654
Archrock
AROC
$6.03B
| $1.01M | ﹤0.01% |
188,379
+56,159
| +42% | +$367K |
|
2655
PUT
Cleveland-Cliffs
CLF
$6.78B
| $1.01M | ﹤0.01% |
157,940
-960
| -0.6% | -$5.78K |
|
2656
Alpha Pro Tech
APT
$55.6M
| $1.01M | ﹤0.01% |
68,461
-978
| -1% | -$16.6K |
|
2657
Oxford Industries
OXM
$534M
| $1.01M | ﹤0.01% |
25,022
+366
| +1% | +$16.5K |
|
2658
CALL
Microchip Technology
MCHP
$42.4B
| $1.01M | ﹤0.01% |
19,600
-4,400
| -18% | -$229K |
|
2659
PUT
Wheaton Precious Metals
WPM
$60.8B
| $1.01M | ﹤0.01% |
20,500
| – | – |
|
2660
PUT
ICU Medical
ICUI
$4.59B
| $1M | ﹤0.01% |
5,500
-2,300
| -29% | -$433K |
|
|
VBTX
2661
DELISTED
Veritex Holdings
VBTX
| $1M | ﹤0.01% |
58,993
+15,981
| +37% | +$276K |
|
2662
Ryder
R
$10.1B
| $1M | ﹤0.01% |
23,753
-29,334
| -55% | -$1.19M |
|
2663
CALL
New Oriental
EDU
$8.33B
| $1M | ﹤0.01% |
6,700
-46,700
| -87% | -$6.75M |
|
2664
Workiva
WK
$3.89B
| $1M | ﹤0.01% |
17,970
-3,494
| -16% | -$194K |
|
|
HTLF
2665
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1M | ﹤0.01% |
33,419
-2,753
| -8% | -$88.4K |
|
2666
Hudbay
HBM
$11.9B
| $1M | ﹤0.01% |
+236,300
| New | +$909K |
|
2667
Pilgrim's Pride
PPC
$6.58B
| $1M | ﹤0.01% |
66,875
+717
| +1% | +$11.5K |
|
2668
TD Synnex
SNX
$20.4B
| $1M | ﹤0.01% |
14,276
-1,500
| -10% | -$94.4K |
|
|
MYOV
2669
DELISTED
Myovant Sciences Ltd.
MYOV
| $1M | ﹤0.01% |
71,200
-8,200
| -10% | -$153K |
|
2670
Arcus Biosciences
RCUS
$3.64B
| $995K | ﹤0.01% |
57,985
+5,836
| +11% | +$130K |
|
2671
Scansource
SCSC
$1.07B
| $994K | ﹤0.01% |
50,134
+19,592
| +64% | +$444K |
|
|
TBIO
2672
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $994K | ﹤0.01% |
73,039
+25,791
| +55% | +$398K |
|
2673
PUT
AngloGold Ashanti
AU
$48.6B
| $992K | ﹤0.01% |
37,600
-16,300
| -30% | -$487K |
|
2674
United Therapeutics
UTHR
$21.4B
| $992K | ﹤0.01% |
9,803
-6,027
| -38% | -$661K |
|
2675
E.W. Scripps
SSP
$315M
| $990K | ﹤0.01% |
86,626
+10,231
| +13% | +$112K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.